MGLCX | RRGAX | MGLCX / RRGAX | |
Total Expense Ratio | 1.94 | 1.20 | 162% |
Annual Report Gross Expense Ratio | 1.95 | 1.39 | 140% |
Fund Existence | 11 years | 19 years | - |
Gain YTD | 3.043 | 5.759 | 53% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.22B | 160M | 1,384% |
Annual Yield % from dividends | 1.29 | 2.10 | 61% |
Returns for 1 year | 1.39 | 7.45 | 19% |
Returns for 3 years | -6.36 | 10.14 | -63% |
Returns for 5 years | 9.38 | 21.76 | 43% |
Returns for 10 years | 9.12 | 18.88 | 48% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HAGIX | 83.44 | 0.75 | +0.91% |
Carillon Eagle Mid Cap Growth I | |||
GLCTX | 32.10 | 0.19 | +0.60% |
Goldman Sachs Large Cap Gr Insghts Inv | |||
BUFEX | 58.96 | 0.22 | +0.37% |
Buffalo Blue Chip Growth | |||
GCVTX | 24.41 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts Inv | |||
LHCCX | 17.55 | 0.05 | +0.29% |
Lord Abbett Health Care C |